Search results for "lcsh:Medical emergencies. Critical care. Intensive care. First aid"

showing 10 items of 44 documents

Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients

2017

0301 basic medicineContinuous renal replacement therapymedicine.medical_specialtyLetterCritical Illness030106 microbiologyHemodiafiltrationCritical Care and Intensive Care MedicineEchinocandinsLipopeptides03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCaspofunginHumansMedicineIntensive care medicinebusiness.industryCritically illlcsh:Medical emergencies. Critical care. Intensive care. First aid030208 emergency & critical care medicinelcsh:RC86-88.9Invasive candidiasisContinuous venovenous hemodiafiltrationAcute Kidney Injurymedicine.diseaseInvasive candidiasisRenal Replacement TherapychemistryAdsorptionCaspofunginbusinessCritical Care
researchProduct

Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris

2018

Abstract Candida spp. infections are a major cause of morbidity and mortality in critically ill patients. Candida auris is an emerging multi-drug-resistant fungus that is rapidly spreading worldwide. Since the first reports in 2009, many isolates across five continents have been identified as agents of hospital-associated infections. Independent and simultaneous outbreaks of C. auris are becoming a major concern for healthcare and scientific community. Moreover, laboratory misidentification and multi-drug-resistant profiles, rarely observed for other non-albicans Candida species, result in difficult eradication and frequent therapeutic failures of C. auris infections. The aim of this review…

0301 basic medicineSettore MED/07 - Microbiologia E Microbiologia Clinicamedicine.medical_specialty030106 microbiologySettore MED/41 - AnestesiologiaVirulenceAntimicrobial resistanceCritical Care and Intensive Care MedicineMicrobiology03 medical and health sciencesInvasive fungal infectionAntibiotic resistanceEpidemiologymedicineCandidaResistance (ecology)business.industryCritically illlcsh:Medical emergencies. Critical care. Intensive care. First aidCandidemiaOutbreakAntifungal resistancelcsh:RC86-88.9Candida aurisCandida sppC. aurisC. auris Candida Candidemia Invasive fungal infection Antimicrobial resistance Antifungal resistancebusinessJournal of Intensive Care
researchProduct

Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review

2021

Abstract Background The mortality of critically ill patients with COVID-19 is high, particularly among those receiving mechanical ventilation (MV). Despite the high number of patients treated worldwide, data on respiratory mechanics are currently scarce and the optimal setting of MV remains to be defined. This scoping review aims to provide an overview of available data about respiratory mechanics, gas exchange and MV settings in patients admitted to intensive care units (ICUs) for COVID-19-associated acute respiratory failure, and to identify knowledge gaps. Main text PubMed, EMBASE, and MEDLINE databases were searched from inception to October 30, 2020 for studies providing at least one v…

ARDSmedicine.medical_specialtyCritical Illnessmedicine.medical_treatmentReviewRespiratory physiologyCritical Care and Intensive Care MedicineHypoxemia03 medical and health sciencesMechanical ventilation0302 clinical medicineIntensive careFraction of inspired oxygenmedicineHumansIntensive care unitMechanical ventilation.Positive end-expiratory pressureMechanical ventilationRespiratory Distress SyndromeIntensive care unitsCoronavirus disease 2019Acute respiratory distress syndromebusiness.industrylcsh:Medical emergencies. Critical care. Intensive care. First aidCOVID-19030208 emergency & critical care medicinelcsh:RC86-88.9medicine.diseaseRespiration Artificial030228 respiratory systemEmergency medicineRespiratory Mechanicsmedicine.symptombusinessCohort studyCritical Care
researchProduct

Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: Insights from the LUNG SAFE study

2020

Abstract Background Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence o…

ARDSmedicine.medical_treatment030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineHyperoxemiaHypoxemialaw.inventionHypoxemia0302 clinical medicinelawFraction of inspired oxygenOxygen therapyPrevalenceMedicineHypoxiaAcute respiratory distress syndrome; Hyperoxemia; Hyperoxia; Hypoxemia; Hypoxia; Invasive mechanical ventilation; Mortality; Oxygen therapy;Respiratory Distress SyndromeHyperbaric OxygenationAcute respiratory distress syndromeRespirationlcsh:Medical emergencies. Critical care. Intensive care. First aidHyperoxemiaIntensive care unitIntensive Care UnitsAnesthesiaArtificialmedicine.symptomHumanArtificial ventilationAcute respiratory distress syndrome; Hyperoxemia; Hyperoxia; Hypoxemia; Hypoxia; Invasive mechanical ventilation; Mortality; Oxygen therapyIntensive Care UnitHyperoxiaNO03 medical and health sciencesIntensive careSettore MED/41 - ANESTESIOLOGIAHumansInvasive mechanical ventilationMortalitybusiness.industryResearchRespiratory Distress Syndrome Adultlcsh:RC86-88.9medicine.diseaseOxygen therapyRespiration Artificialrespiratory tract diseasesOxygenlnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]030228 respiratory systembusiness
researchProduct

Acute cholecystitis during COVID-19 pandemic: a multisocietary position statement

2020

AbstractFollowing the spread of the infection from the new SARS-CoV2 coronavirus in March 2020, several surgical societies have released their recommendations to manage the implications of the COVID-19 pandemic for the daily clinical practice. The recommendations on emergency surgery have fueled a debate among surgeons on an international level.We maintain that laparoscopic cholecystectomy remains the treatment of choice for acute cholecystitis, even in the COVID-19 era. Moreover, since laparoscopic cholecystectomy is not more likely to spread the COVID-19 infection than open cholecystectomy, it must be organized in such a way as to be carried out safely even in the present situation, to gu…

Acute cholecystitis; COVID-19 pandemic; Emergency surgery; New coronavirus; Position statement; Betacoronavirus; COVID-19; Cholecystectomy; Cholecystitis Acute; Coronavirus Infections; Humans; Infection Control; Pandemics; Pneumonia Viral; SARS-CoV-2; Societies Medical; Practice Guidelines as Topicmedicine.medical_treatmentCholecystitis AcutePosition statement030230 surgery0302 clinical medicinePandemicCholecystitisInfection control030212 general & internal medicineViralSocieties Medicallcsh:Medical emergencies. Critical care. Intensive care. First aidPractice Guidelines as TopicEmergency MedicineEmergency surgeryAcute cholecystitis Emergency surgery COVID-19 pandemic New coronavirus Position statementCoronavirus InfectionsHumanPosition statementmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia Virallcsh:SurgeryCOVID-19 pandemicNew coronaviruAcuteAcute cholecystitiacute cholecystitis; COVID-19 pandemic; emergency surgery; Nnew coronavirus; position statement; betacoronavirus; cholecystectomy; cholecystitis acute; coronavirus infections; humans; infection control; pandemics; pneumonia viral; societies medical; practice guidelines as topicNO03 medical and health sciencesBetacoronavirusEmergency surgeryMedicalmedicineAcute cholecystitisHumansCholecystectomyPandemicsAcute cholecystitis; COVID-19 pandemic; Emergency surgery; New coronavirus; Position statement; Betacoronavirus; Cholecystectomy; Cholecystitis Acute; Coronavirus Infections; Humans; Infection Control; Pandemics; Pneumonia Viral; Societies Medical; Practice Guidelines as TopicInfection ControlBetacoronaviruPandemicbusiness.industrySARS-CoV-2Coronavirus InfectionGeneral surgeryCOVID-19New coronavirusPneumonialcsh:RD1-811lcsh:RC86-88.9Acute cholecystitisSettore MED/18 - Chirurgia GeneraleInvasive surgeryCommentarySurgeryCholecystectomybusinessSocietiesWorld Journal of Emergency Surgery
researchProduct

Procalcitonin levels in candidemia versus bacteremia: a systematic review

2019

Background Procalcitonin (PCT) is a biomarker used to assess systemic inflammation, infection, and sepsis and to optimize antimicrobial therapies. Its role in the in the differential diagnosis between candidemia and bacteremia is unclear. The aim of this systematic review was to summarize the current evidence about PCT values for differentiating candidemia from bacteremia. Methods PubMed and EMBASE were searched for studies reporting data on the diagnostic performance of serum PCT levels in intensive care unit (ICU) or non-ICU adult patients with candidemia, in comparison to patients with bacteremia. Results We included 16 studies for a total of 45.079 patients and 785 cases of candidemia. …

AdultMaleCalcitoninmedicine.medical_specialtyLetterBacteremiaCritical Care and Intensive Care MedicineProcalcitoninlaw.inventionSepsis03 medical and health sciences0302 clinical medicineBiomarker; Candida; Candidemia; Fungal; Fungi; PCT; Procalcitonin; SepsislawSecondary analysisSepsisparasitic diseasesmedicineHumansIntensive care medicineCandidaAdult patientsbusiness.industryResearchlcsh:Medical emergencies. Critical care. Intensive care. First aidFungiCandidemia030208 emergency & critical care medicinelcsh:RC86-88.9Biomarkermedicine.diseasebacterial infections and mycosesIntensive care unitFungalBacteremiaBiomarker (medicine)FemaleDifferential diagnosisbusinessPCTProcalcitoninhormones hormone substitutes and hormone antagonistsBiomarkersCritical Care
researchProduct

Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis o…

2018

Background: Diabetes mellitus is a common co-existing disease in the critically ill. Diabetes mellitus may reduce the risk of acute respiratory distress syndrome (ARDS), but data from previous studies are conflicting. The objective of this study was to evaluate associations between pre-existing diabetes mellitus and ARDS in critically ill patients with acute hypoxemic respiratory failure (AHRF). Methods: An ancillary analysis of a global, multi-centre prospective observational study (LUNG SAFE) was undertaken. LUNG SAFE evaluated all patients admitted to an intensive care unit (ICU) over a 4-week period, that required mechanical ventilation and met AHRF criteria. Patients who had their AHRF…

AdultMaleDiabetes mellituLUNG SAFEOrgan Dysfunction Scoreshumanoslnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]Socio-culturaleOrgan Dysfunction ScoreDiabetes ComplicationsDiabetes mellituspuntuaciones de disfunción orgánicaRisk FactorsDiabetes Complicationestudios prospectivosHumansfactores de riesgoProspective StudiesHospital MortalityHypoxiamediana edadAcute hypoxemic respiratory failureAgedRespiratory Distress SyndromeancianoAcute respiratory distress syndromeResearchRespirationrespiraciónRespiratory Distress Syndrome Adultlcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RC86-88.9Middle AgedRespiration Artificialinsuficiencia respiratoriaAcute hypoxemic respiratory failure; Acute respiratory distress syndrome; Diabetes mellitus; LUNG SAFEProspective StudieArtificialAcute hypoxemic respiratory failure; Acute respiratory distress syndrome; Diabetes mellitus; LUNG SAFE; Aged; Diabetes Complications; Diabetes Mellitus; Female; Hospital Mortality; Humans; Hypoxia; Male; Middle Aged; Organ Dysfunction Scores; Prospective Studies; Respiration Artificial; Respiratory Distress Syndrome Adult; Respiratory Insufficiency; Risk FactorsFemaleRespiratory Insufficiencymortalidad hospitalariacomplicaciones de la diabetesHuman
researchProduct

Extravascular Lung Water Does Not Increase in Hypovolemic Patients after a Fluid-Loading Protocol Guided by the Stroke Volume Variation

2012

Introduction. Circulatory failure secondary to hypovolemia is a common situation in critical care patients. Volume replacement is the first option for the treatment of hypovolemia. A possible complication of volume loading is pulmonary edema, quantified at the bedside by the measurement of extravascular lung water index (ELWI). ELWI predicts progression to acute lung injury (ALI) in patients with risk factors for developing it. The aim of this study was to assess whether fluid loading guided by the stroke volume variation (SVV), in patients presumed to be hypovolemic, increased ELWI or not.Methods. Prospective study of 17 consecutive postoperative, fully mechanically ventilated patients dia…

Article Subjectbusiness.industrylcsh:Medical emergencies. Critical care. Intensive care. First aidCardiac indexHemodynamicslcsh:RC86-88.9Stroke volumeLung injuryCritical Care and Intensive Care MedicinePulmonary edemamedicine.diseaseHypovolemiaAnesthesiaClinical StudymedicineSinus rhythmmedicine.symptomComplicationbusinessCritical Care Research and Practice
researchProduct

Global warming “heating up” the ICU through Candida auris infections: the climate changes theory

2019

The most enigmatic aspect of the rise of Candida auris as a human pathogen is that it emerged simultaneously on three continents, with each clade being genetically distinct. Although new pathogenic fungal species are described regularly, these are mostly species associated with single cases in individuals who are immunosuppressed.

Candida sppmedicine.medical_specialtybusiness.industryGlobal warmingfungusMEDLINElcsh:Medical emergencies. Critical care. Intensive care. First aidClimate changeOpinion/Hypothesislcsh:RC86-88.9Candida aurisCritical Care and Intensive Care MedicineHost-Microbe Biologyclimate changeCandida aurisEmergency medicineCandida sppMedicinebusinessCandidaCritical Care
researchProduct

Chloroquine for COVID-19: rationale, facts, hopes

2020

The tragedy of the pandemic coronavirus disease 2019 (COVID-19) led to a desperate search for effective treatments. Chloroquine (CQ), an aminoquinoline used for many years for the prophylaxis and therapy of malaria and autoimmune diseases, has been put forward as a treatment option. The fact that CQ is not patented and has been in clinical use for years is a major advantage. CQ has been shown to have antiviral effects in SARS, MERS, Ebola, and HIV infections, but without data showing clinical effectiveness [1, 2]. Does the current level of evidence suffice for prescribing CQ for COVID-19?

Coronavirus disease 2019 (COVID-19)Treatment outcomeCoronaviruPneumonia ViralMEDLINECritical Care and Intensive Care Medicinemedicine.disease_causeAntiviral AgentsAntimalarialsBetacoronavirusChloroquinePandemicmedicineHumansPandemicsCoronavirusClinical Trials as Topicbiologybusiness.industrySARS-CoV-2lcsh:Medical emergencies. Critical care. Intensive care. First aidCOVID-19Chloroquinelcsh:RC86-88.9Pneumoniabiology.organism_classificationmedicine.diseaseVirologyCOVID-19 Drug TreatmentCoronavirusPneumoniaTreatment OutcomeEditorialbusinessCoronavirus InfectionsCOVID-19 ; Chloroquine ; Pneumonia ; SARS-CoV-2 ; CoronavirusBetacoronavirusmedicine.drug
researchProduct